Fig. 4From: Advances in treatment strategies based on scavenging reactive oxygen species of nanoparticles for atherosclerosisThe diagram shows the preparation of SHPEMs and the targeting of SHPEMs across ECs to CD44 receptors on macrophages within the plaque, followed by nanoparticle disintegration for anti-inflammatory and ROS depletion purposes. Copyright 2020 by Mu [104]Back to article page